CIPO Patents = 1

EPO Patents = 1

Trademarks = 4

Forward Citations = 0

Loading Chart...

5 inventors (with patents filed for the assignee):

Andrew G Reaume (4 out of 20 patents)

Michael S Saporito (4 out of 17 patents)

John Ciallella (2 out of 5 patents)

4. John Gruner (2 out of 5 patents)

5. Heather Hain (2 out of 2 patents)

4 patents: Sort by Forward Citations

1. 9408844 - Methods for treating inflammatory conditions (2016-08-09),

2. 9402830 - Methods of treating dyskinesia and related disorders (2016-08-02),

3. 9051312 - Methods of treating dyskinesia and related disorders (2015-06-09),

4. 8716294 - Methods for treating inflammatory conditions (2014-05-06),

Melior Discovery, Inc. is a biopharmaceutical company focused on developing novel therapeutics for metabolic diseases and inflammatory conditions. With a unique approach to drug discovery, Melior utilizes its proprietary theraTRACE platform to identify and optimize drug candidates with high efficacy and minimal side effects. The company has a strong pipeline of compounds in various stages of development and a track record of successful partnerships with pharmaceutical companies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#40 in Exton, PA

#2,183 in Pennsylvania

#58,999 in US

Exton, PA, United States of America

Melior Discovery, Inc.

Forward Citations = 0

5 inventors:

Andrew G Reaume (4 out of 20 patents)

Michael S Saporito (4 out of 17 patents)

John Ciallella (2 out of 5 patents)

4. John Gruner (2 out of 5 patents)

5. Heather Hain (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com